FDA Approves Expanded Access Program For Lipella Pharma's LP-310 In Oral Lichen Planus; Stock Up
Lipella Pharmaceuticals Inc. (LIPO), a clinical-stage biotechnology company, Wednesday said that the U.S. Food and Drug ...
FDA approves Lipella's oral treatment access program
PITTSBURGH - Lipella Pharmaceuticals Inc. (NASDAQ:LIPO), a biotech firm specializing in novel therapies for medical conditions lacking adequate treatments, has received FDA approval for an Expanded ...
Lipella Pharmaceuticals Granted FDA Approval for Expanded Access Program for LP-310 in Oral Lichen Planus
The FDA’s approval for expanded use reinforces LP-310’s potential as a new therapeutic option for OLP and supports ongoing clinical development efforts.
Pet flea treatments may be harming wildlife—but owners can help
Toxic substances used in flea and tick treatments pet owners give to their dogs and cats have been detected in birds' nests, ...
Alzheimer's Research UK2d
New Alzheimer’s treatments
These are known as disease-modifying treatments and have been licensed for private use. Other medications are under review to see if they could be prescribed to people in the very early stages of ...
Cuteness on MSN3d
Bugs That Pose The Biggest Risk To Your Pets Outdoors
When your pet heads outside, they can come into contact with some pesky pests. Here are the most common ones to look out for ...